Clinical Trial Update: To Study Different Levels of MK0493 for Safety, Efficacy, and Tolerability in Obese Patients (0493-017)(COMPLETED) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating different dose levels of MK0493 for safety, efficacy, and tolerability in obese patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• MK0493

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED